脂蛋白质结晶病与芬纤维酸完全解决:来自巴基斯坦的第一例病例报告
Nada Shaker1, Ruwaida Ben Musa2, Nuha Shaker3
1Department of Pathology, The Ohio State University Wexner Medical Center/James Cancer Hospital, Columbus, USA.
International journal of surgical pathology
|February 8, 2024
概括
这份病例报告详细介绍了巴基斯坦首次记录的脂蛋白球瘤病例,这是一种罕见的脏疾病. 用费诺纤维酸盐,罗斯瓦斯塔丁和卡普托普里尔治疗在一名年轻男性患者中显示出显著改善.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 病理学 病理学 病理学
- 流行病学 流行病学
背景情况:
- 脂质蛋白球性病是一种罕见的球性疾病,导致脏综合征和功能衰竭.
- 大多数报告的病例来自日本和中国,其他地方的文档有限.
- 这项研究介绍了在巴基斯坦发现的第一例脂蛋白球蛋白病例.
研究的目的:
- 在巴基斯坦报告了第一例脂蛋白质结晶病例.
- 描述组织病理学特征和临床表现.
- 为了评估巴基斯坦患者的治疗反应.
主要方法:
- 一名25岁的男性患有高血压,出现了胀和泡的尿液.
- 脏活检显示了球毛细血管内特有的脂蛋白血栓.
- 电子显微镜证实了瘤的丰富脂质性质.
- 治疗包括费诺纤维酸,罗斯瓦斯塔丁和卡普托普里尔.
主要成果:
- 该患者表现出性综合征,脂质和蛋白质尿的升高.
- 脏活检证实了脂蛋白质血球病变与脂蛋白质瘤.
- 治疗导致症状缓解,血压改善,脂质水平正常化.
- 随访活检表明,脂蛋白血栓的解决,但持续的子内皮质物质.
结论:
- 在巴基斯坦,脂蛋白质结晶病很少见,这突显了需要提高认识的必要性.
- 芬诺纤维酸在治疗这种疾病方面表现出有效性.
- 这一案例有助于了解脂蛋白结晶病变的全球流行病学和病理学.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
661
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
661
Hepatic Drug Clearance: Effect of Protein Binding
198
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
198


